These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 24523037)

  • 21. CYP2C19 metabolizer status and clopidogrel efficacy in the Secondary Prevention of Small Subcortical Strokes (SPS3) study.
    McDonough CW; McClure LA; Mitchell BD; Gong Y; Horenstein RB; Lewis JP; Field TS; Talbert RL; Benavente OR; Johnson JA; Shuldiner AR
    J Am Heart Assoc; 2015 May; 4(6):e001652. PubMed ID: 26019129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.
    Dosh K; Berger PB; Marso S; van Lente F; Brennan DM; Charnigo R; Topol EJ; Steinhubl S
    Circ Cardiovasc Interv; 2009 Dec; 2(6):503-12. PubMed ID: 20031767
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trials.
    Palacio S; Hart RG; Pearce LA; Benavente OR
    Stroke; 2012 Aug; 43(8):2157-62. PubMed ID: 22826359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack.
    Li Z; Wang Y; Zhao X; Liu L; Wang D; Wang C; Meng X; Li H; Pan Y; Wang X; Wang C; Yang X; Zhang C; Jing J; Xian Y; Johnston SC; Wang Y;
    J Am Heart Assoc; 2016 Mar; 5(3):e003038. PubMed ID: 27001965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels.
    Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C
    Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent Ischemic Lesions After Acute Atherothrombotic Stroke: Clopidogrel Plus Aspirin Versus Aspirin Alone.
    Hong KS; Lee SH; Kim EG; Cho KH; Chang DI; Rha JH; Bae HJ; Lee KB; Kim DE; Park JM; Kim HY; Cha JK; Yu KH; Lee YS; Lee SJ; Choi JC; Cho YJ; Kwon SU; Kim GM; Sohn SI; Park KY; Kang DW; Sohn CH; Lee J; Yoon BW;
    Stroke; 2016 Sep; 47(9):2323-30. PubMed ID: 27418597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study.
    Elkind MS; Luna JM; Moon YP; Liu KM; Spitalnik SL; Paik MC; Sacco RL
    Neurology; 2009 Oct; 73(16):1300-7. PubMed ID: 19841382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.
    Sacco RL; Diener HC; Yusuf S; Cotton D; Ounpuu S; Lawton WA; Palesch Y; Martin RH; Albers GW; Bath P; Bornstein N; Chan BP; Chen ST; Cunha L; Dahlöf B; De Keyser J; Donnan GA; Estol C; Gorelick P; Gu V; Hermansson K; Hilbrich L; Kaste M; Lu C; Machnig T; Pais P; Roberts R; Skvortsova V; Teal P; Toni D; Vandermaelen C; Voigt T; Weber M; Yoon BW;
    N Engl J Med; 2008 Sep; 359(12):1238-51. PubMed ID: 18753638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-sensitive C-reactive protein and dual antiplatelet in intracranial arterial stenosis.
    Li J; Wang A; Zhao X; Liu L; Meng X; Lin J; Jing J; Zou X; Wang Y; Wang Y;
    Neurology; 2018 Feb; 90(6):e447-e454. PubMed ID: 29330312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features and racial/ethnic differences among the 3020 participants in the Secondary Prevention of Small Subcortical Strokes (SPS3) trial.
    White CL; Szychowski JM; Roldan A; Benavente MF; Pretell EJ; Del Brutto OH; Kase CS; Arauz A; Meyer BC; Meissner I; Demaerschalk BM; McClure LA; Coffey CS; Pearce LA; Conwit R; Irby LH; Peri K; Pergola PE; Hart RG; Benavente OR;
    J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):764-74. PubMed ID: 22516427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel protein glycan biomarker and future cardiovascular disease events.
    Akinkuolie AO; Buring JE; Ridker PM; Mora S
    J Am Heart Assoc; 2014 Sep; 3(5):e001221. PubMed ID: 25249300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study design and rationale of 'Influence of Cilostazol-based triple anti-platelet therapy on ischemic complication after drug-eluting stent implantation (CILON-T)' study: A multicenter randomized trial evaluating the efficacy of Cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease.
    Lee SP; Suh JW; Park KW; Lee HY; Kang HJ; Koo BK; Chae IH; Choi DJ; Rha SW; Bae JW; Cho MC; Kwon TG; Bae JH; Kim HS;
    Trials; 2010 Aug; 11():87. PubMed ID: 20735821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
    Jamieson DG; Parekh A; Ezekowitz MD
    J Cardiovasc Pharmacol Ther; 2005 Sep; 10(3):153-61. PubMed ID: 16211203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Should Blood Pressure Targets After Lacunar Stroke Vary by Body Size? The SPS3 Trial.
    Field TS; McClure LA; White CL; Pergola PE; Hart RG; Benavente OR; Hill MD;
    Am J Hypertens; 2015 Jun; 28(6):756-64. PubMed ID: 25452300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiplatelet treatment for prevention of cerebrovascular events in patients with vascular diseases: a systematic review and meta-analysis.
    Gouya G; Arrich J; Wolzt M; Huber K; Verheugt FW; Gurbel PA; Pirker-Kees A; Siller-Matula JM
    Stroke; 2014 Feb; 45(2):492-503. PubMed ID: 24368560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does all single infarction have lower risk of stroke recurrence than multiple infarctions in minor stroke?
    Wang G; Jing J; Pan Y; Meng X; Zhao X; Liu L; Li H; Wang D; Wang Y; Wang Y;
    BMC Neurol; 2019 Jan; 19(1):7. PubMed ID: 30621613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study.
    Kohli P; Wallentin L; Reyes E; Horrow J; Husted S; Angiolillo DJ; Ardissino D; Maurer G; Morais J; Nicolau JC; Oto A; Storey RF; James SK; Cannon CP
    Circulation; 2013 Feb; 127(6):673-80. PubMed ID: 23277305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of stroke recurrence in patients with recent lacunar stroke and response to interventions according to risk status: secondary prevention of small subcortical strokes trial.
    Hart RG; Pearce LA; Bakheet MF; Benavente OR; Conwit RA; McClure LA; Talbert RL; Anderson DC
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):618-24. PubMed ID: 23800503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical correlates of infarct shape and volume in lacunar strokes: the Secondary Prevention of Small Subcortical Strokes trial.
    Asdaghi N; Pearce LA; Nakajima M; Field TS; Bazan C; Cermeno F; McClure LA; Anderson DC; Hart RG; Benavente OR;
    Stroke; 2014 Oct; 45(10):2952-8. PubMed ID: 25190442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral White Matter Hyperintensities, Kidney Function Decline, and Recurrent Stroke After Intensive Blood Pressure Lowering: Results From the Secondary Prevention of Small Subcortical Strokes ( SPS 3) Trial.
    Ikeme JC; Pergola PE; Scherzer R; Shlipak MG; Catanese L; McClure LA; Benavente OR; Peralta CA
    J Am Heart Assoc; 2019 Feb; 8(3):e010091. PubMed ID: 30686103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.